Cite
Clonal haematopoiesis of indeterminate potential among cancer survivors exposed to myelotoxic chemotherapy
MLA
Celine Hamel, et al. “Clonal Haematopoiesis of Indeterminate Potential among Cancer Survivors Exposed to Myelotoxic Chemotherapy.” British Journal of Haematology, vol. 186, Mar. 2019. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....7df92ce1d9400866604d2f1f44797ec4&authtype=sso&custid=ns315887.
APA
Celine Hamel, Max Petersen, Peter J. Quesenberry, John L. Reagan, Anna Chorzalska, Jordan Robison, Mary Anne Fenton, Mary L Lopresti, James N. Butera, Annette S. Kim, Patrycja M. Dubielecka, Ilyas Sahin, & Adam J. Olszewski. (2019). Clonal haematopoiesis of indeterminate potential among cancer survivors exposed to myelotoxic chemotherapy. British Journal of Haematology, 186.
Chicago
Celine Hamel, Max Petersen, Peter J. Quesenberry, John L. Reagan, Anna Chorzalska, Jordan Robison, Mary Anne Fenton, et al. 2019. “Clonal Haematopoiesis of Indeterminate Potential among Cancer Survivors Exposed to Myelotoxic Chemotherapy.” British Journal of Haematology 186 (March). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....7df92ce1d9400866604d2f1f44797ec4&authtype=sso&custid=ns315887.